Causal association of circulating cholesterol levels with dementia: a mendelian randomization meta-analysis
Open Access
- 12 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Psychiatry
- Vol. 10 (1), 1-8
- https://doi.org/10.1038/s41398-020-0822-x
Abstract
Prospective studies have shown that abnormally circulating cholesterol is associated with the risk of dementia. However, whether the association is causal or not remains unclear. We attempt to infer the causal association in a MR meta-analysis by using ApoE gene polymorphisms as instrument variables. Studies with dementia risk (27 studies) or circulating lipid levels (7 studies) were included, with totally 3136 dementia patients and 3103 healthy controls. The analyses showed that carriers of ε2 allele significantly were of decreased risk of AD (OR = 0.70; 95% CI: 0.58–0.84; P < 0.01), whereas carriers of ε4 allele were of increased risk of AD (OR = 3.62; 95% CI: 3.03–4.32; P < 0.05), compared to these of ε3 allele. Circulating TC was significantly reduced in carriers of ε2 allele (WMD = − 0.29 mmol/L; 95% CI: −0.54 to −0.03; P < 0.05) and increased in carriers of ε4 allele (WMD = 0.42 mmol/l; 95% CI: 0.001–0.84; P < 0.05). In addition, carriers of ε4 allele had reduction in circulating HDL-C (WMD = − 0.04 mmol/L; 95% CI: − 0.07 to −0.001; P < 0.05). In comparing allele ε2 with ε3, the predicted OR of having AD for 1 mg/dL increment in circulating TC was 0.97 (95% CI: 0.86–0.98; P < 0.05). Comparing allele ε4 with ε3, the predicted OR for a 1 mg/dL increment in TC was 1.08 (95% CI: 1.05–17.58; P < 0.05), and reduction in HDL-C was 2.30 (95% CI: 1.51–43.99; P < 0.05). Our findings demonstrate that high circulating TC and reduced HDL-C levels might be potential risk factors of the development of AD.This publication has 58 references indexed in Scilit:
- Impact of APOE gene polymorphisms on the lipid profile in an Algerian populationLipids in Health and Disease, 2013
- Association of an apolipoprotein E polymorphism with circulating cholesterols and hypertension: a meta-based Mendelian randomization analysisHypertension Research, 2011
- Association of Higher Levels of High-Density Lipoprotein Cholesterol in Elderly Individuals and Lower Risk of Late-Onset Alzheimer DiseaseArchives of Neurology, 2010
- The 32-year relationship between cholesterol and dementia from midlife to late lifeNeurology, 2010
- A Summary Risk Score for the Prediction of Alzheimer Disease in Elderly PersonsArchives of Neurology, 2010
- Oxysterols and neurodegenerative diseasesMolecular Aspects of Medicine, 2009
- Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's diseaseNeuroscience Letters, 2006
- Measuring inconsistency in meta-analysesBMJ, 2003
- Elevated Serum Total and LDL Cholesterol in Very Old Patients with Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2001
- Apolipoprotein E polymorphism in health and diseaseAmerican Heart Journal, 1987